Table 3 Descriptive statistics of each MDR microorganism regarding antibiotic combinations and affected systems
Parameter | MDR Acinetobacter (n=14) | MDR Klebsiella (n=12) | MDR Pseudomonas (n=2) |
|---|---|---|---|
Antibiotic used | |||
Piperacillin Tazobactam + Colistimethate sodium | 5 (35.7%) | 8 (66.6%) | 2 (100%) |
Imipenem+ Colistimethate sodium | 6 (42.8%) | 4 (33.3%) | - |
Ceftazidime-Clindamycin – Amikacin | - | 1 (8.3%) | - |
Colistimethate sodium and Ciprofloxacin | 1 (7.1%) | - | - |
Piperacillin Amikacin | 1 (7.1%) | - | - |
Meropenem+ Amikacin | 1 (7.1%) | - | - |
Samples | |||
Sputum | 10 (71.4%) | 5 (41.6%) | - |
Blood | 2 (14.3%) | 4 (33.3%) | 1 (50%) |
Urine | 2 (14.3%) | 3 (25%) | 1 (50%) |